SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 131 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $264,000 | -52.6% | 90,922 | -27.4% | 0.03% | -57.1% |
Q2 2017 | $557,000 | -63.3% | 125,252 | -55.0% | 0.06% | -57.4% |
Q1 2017 | $1,518,000 | +62.5% | 278,628 | +81.7% | 0.15% | +16.5% |
Q4 2016 | $934,000 | +641.3% | 153,376 | +569.9% | 0.13% | +647.1% |
Q3 2016 | $126,000 | -93.0% | 22,896 | -95.2% | 0.02% | -92.9% |
Q2 2016 | $1,804,000 | -34.6% | 474,788 | -52.5% | 0.24% | -28.5% |
Q1 2016 | $2,760,000 | +773.4% | 1,000,000 | +1693.9% | 0.33% | +753.8% |
Q4 2015 | $316,000 | +15.8% | 55,746 | +8.2% | 0.04% | +5.4% |
Q3 2015 | $273,000 | -41.4% | 51,500 | -8.2% | 0.04% | -53.2% |
Q2 2015 | $466,000 | +91.0% | 56,100 | +6.2% | 0.08% | +21.5% |
Q1 2015 | $244,000 | – | 52,800 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |